Earnings

Microsoft delivered picture-perfect earnings after the bell Thursday, calming the market’s brief fears about runaway spending on AI infrastructure without the cloud revenues to show for it. Revenue increased about 17% year over year, to $61.86 billion, beating the Street consensus estimate of $60.8 billion, according to data from LSEG. Earnings per share (EPS) increased

In this article CVX Follow your favorite stocksCREATE FREE ACCOUNT Gas pumps are seen at a Chevron gas station in Orlando.  Paul Hennessy | SOPA Images | Lightrocket | Getty Images Chevron beat earnings expectations Friday, but its profit fell from the year-ago period as its refineries and international gas business faced headwinds. The oil

In this article AIR-FR Follow your favorite stocksCREATE FREE ACCOUNT An Airbus employee works on an aircraft part of the Airbus A350 at the Airbus Atlantic plant in Bouguenais, near Nantes, western France, on Feb. 29, 2024. Sebastien Salom-gomis | Afp | Getty Images Airbus is ramping up production of its A350 aircraft because of

An Exxon gas station is seen on October 06, 2023 in the Brooklyn borough of New York City. Michael M. Santiago | Getty Images Exxon Mobil on Friday reported first-quarter earnings that missed expectations as the industry came under pressure from eroding refining margins and collapsing natural gas prices. Exxon’s stock was down less than

Alphabet on Thursday delivered a knockout first-quarter report, with sales, operating margin and profits all topping Wall Street expectations. The search giant also reloaded its stock buyback program and initiated a quarterly dividend for the first time in its history. Total revenue in the three months ended March 31 rose 15.4% year over year to

Honeywell shares are under pressure Thursday, despite the industrial conglomerate exceeding expectations for first-quarter sales and earnings. The culprits: Softer guidance for the current quarter and some uncertainty about a recovery in some of its key businesses. Revenue for the three months ended March 31 totaled $9.1 billion, topping Wall Street expectations of $9.03 billion,

In this article BMY Follow your favorite stocksCREATE FREE ACCOUNT The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023.  Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and

Meta Platforms on Wednesday evening delivered a solid quarter with sales, operating income, earnings, and cash flow all exceeding expectations on the back of a solid increase in engagement. The stock, however, dropped sharply in after-hours trading following some guidance concerns. Revenue in the three months ended March 31 rose 27% year over year to

In this article META Follow your favorite stocksCREATE FREE ACCOUNT Mark Zuckerberg, CEO, Meta Platforms, in July 2021. Kevin Dietsch | Getty Images News | Getty Images Meta will report first-quarter results after the bell Wednesday. Here’s what analysts are expecting. Earnings per share: $4.32, according to LSEG. Revenue: $36.16 billion, according to LSEG. Daily

In this article BIIB Follow your favorite stocksCREATE FREE ACCOUNT A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched

Tesla vehicles sit on the lot at a Tesla dealership on April 15, 2024 in Austin, Texas.  Brandon Bell | Getty Images Tesla is set to report first-quarter earnings after the bell on Tuesday. Here’s what analysts are expecting, according to LSEG: Earnings per share: 51 cents Revenue: $22.15 billion Wall Street is projecting that revenue will

Shares of Danaher popped more than 7% on Tuesday after the life sciences company delivered beats across its three main businesses — a sign the long-awaited turnaround in the biotech industry is finally here. Revenue for the period ended March 29 declined 4% organically year over year to nearly $5.8 billion in total sales, outpacing